NOX1 and atrial fibrillation: NOX1 and NOX4 levels were significantly increased in the myocardium, as well as in cardiomyocytes of neonates treated with doxorubicin [40], a drug that induces cardiovascular toxicity and can cause AF in mice [41] and humans [42].